455 Shares in McKesson Corporation (NYSE:MCK) Bought by Moody Aldrich Partners LLC

Moody Aldrich Partners LLC acquired a new stake in McKesson Corporation (NYSE:MCK - Free Report) during the 1st quarter, according to its most recent filing with the Securities & Exchange Commission. The fund acquired 455 shares of the company's stock, valued at approximately $306,000.

Several other institutional investors and hedge funds have also recently modified their holdings of MCK. GAMMA Investing LLC increased its holdings in shares of McKesson by 75,632.7% in the first quarter. GAMMA Investing LLC now owns 2,393,152 shares of the company's stock valued at $1,610,567,000 after purchasing an additional 2,389,992 shares during the last quarter. Norges Bank acquired a new position in shares of McKesson in the fourth quarter valued at $1,200,361,000. Farallon Capital Management LLC acquired a new position in shares of McKesson in the fourth quarter valued at $348,044,000. Marshall Wace LLP increased its holdings in shares of McKesson by 59,720.3% in the fourth quarter. Marshall Wace LLP now owns 358,922 shares of the company's stock valued at $204,553,000 after purchasing an additional 358,322 shares during the last quarter. Finally, Leigh Baldwin & CO. LLC acquired a new position in shares of McKesson in the fourth quarter valued at $182,861,000. 85.07% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

MCK has been the subject of a number of recent research reports. Cfra Research cut shares of McKesson from a "moderate buy" rating to a "hold" rating in a research report on Friday, April 4th. Wells Fargo & Company set a $766.00 target price on shares of McKesson and gave the company an "equal weight" rating in a research report on Tuesday, June 3rd. UBS Group boosted their target price on shares of McKesson from $708.00 to $805.00 and gave the company a "buy" rating in a research report on Tuesday, April 29th. Wall Street Zen raised shares of McKesson from a "buy" rating to a "strong-buy" rating in a research report on Saturday. Finally, Morgan Stanley boosted their target price on shares of McKesson from $745.00 to $770.00 and gave the company an "overweight" rating in a research report on Wednesday, June 11th. Three analysts have rated the stock with a hold rating, ten have given a buy rating and two have assigned a strong buy rating to the company. According to MarketBeat.com, McKesson presently has an average rating of "Moderate Buy" and an average price target of $696.42.

Insider Buying and Selling at McKesson

In other news, CFO Britt J. Vitalone sold 1,878 shares of the firm's stock in a transaction that occurred on Wednesday, May 28th. The shares were sold at an average price of $717.91, for a total transaction of $1,348,234.98. Following the completion of the sale, the chief financial officer owned 14,028 shares of the company's stock, valued at $10,070,841.48. This trade represents a 11.81% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this link. Also, EVP Leann B. Smith sold 341 shares of the firm's stock in a transaction that occurred on Wednesday, May 28th. The stock was sold at an average price of $717.91, for a total transaction of $244,807.31. Following the sale, the executive vice president directly owned 2,800 shares of the company's stock, valued at approximately $2,010,148. This trade represents a 10.86% decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 33,117 shares of company stock worth $23,526,451. Company insiders own 0.08% of the company's stock.

McKesson Price Performance

McKesson stock opened at $719.30 on Friday. The business has a 50 day moving average of $714.17 and a 200-day moving average of $657.15. The company has a market capitalization of $89.99 billion, a P/E ratio of 27.85, a P/E/G ratio of 1.44 and a beta of 0.48. McKesson Corporation has a 1 year low of $464.42 and a 1 year high of $736.96.

McKesson (NYSE:MCK - Get Free Report) last issued its quarterly earnings data on Thursday, May 8th. The company reported $10.12 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $9.83 by $0.29. The business had revenue of $90.82 billion during the quarter, compared to analyst estimates of $94 billion. McKesson had a net margin of 0.92% and a negative return on equity of 201.12%. The firm's quarterly revenue was up 18.9% on a year-over-year basis. During the same quarter last year, the business earned $6.18 EPS. Equities analysts anticipate that McKesson Corporation will post 32.77 EPS for the current year.

McKesson Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, July 1st. Shareholders of record on Monday, June 2nd were given a dividend of $0.71 per share. This represents a $2.84 dividend on an annualized basis and a yield of 0.39%. The ex-dividend date was Monday, June 2nd. McKesson's dividend payout ratio is presently 10.99%.

McKesson Company Profile

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.